Moreover, overall survival was increased in PBX1 highly expressed ccRCC patients, compared with PBX1 lowly expressed ccRCC patients in TCGA and E-MTAB-1980 datasets (Fig. 3g). Here, PBX1 is linked to nonpapillary renal cell carcinoma.